3 Key Takeaways:
- Cyber threats aren’t just a big corporation problem—life sciences Small-Medium Businesses (SMBs) are prime targets for trade secrets theft, fraud, and insider threats. This is why implementing security awareness training is crucial.
- A single incident can derail years of research, jeopardise IP protection, and destroy investor confidence in commercialisation efforts.
- Security training doesn’t have to be a compliance nightmare—bite-sized, real-world training is key to protecting your supply chain and technology assets.
Your Business Is Sitting on a Data Goldmine—And Criminals Know It
Most founders in life sciences and healthcare are obsessed with research, innovation, and securing funding. If you’re starting or running a business, here’s a reality check: your biggest asset—your intellectual property—is also your biggest liability. This means if you don’t take cybersecurity seriously, you’re rolling out the red carpet for cybercriminals, fraudsters, and insider threats who want a piece of your trade secrets.
Think I’m exaggerating?
- Healthcare is now the 3rd-most targeted industry for ransomware attacks. The increase in attacks on healthcare organizations was 32% year-over-year from 2023 to 2024 (Black Kite)
- 29% of life sciences leaders expect cyber risks to escalate in 2025 (Deloitte’s Life Sciences Outlook).
- An Australian survey found most SMBs can’t even explain the threats they face, yet alone manage them. (ASD ACSC Small Business Cybersecurity Survey).
This isn’t just about data breaches and phishing scams. In 2025, its common to take an exclusively ‘cybersecurity’ view of risk, but if your proprietary research, technology, or supply chain plans leak, you risk losing your competitive edge, damaging investor confidence, and watching years of commercialisation efforts go down the drain. Just look at how your IP is being sold on the dark web.

Why Life Sciences Is a Prime Target
Cybercriminals love life sciences for one reason: high-value data. High-value data provides long-term value, unlike stolen credit card numbers (which lose value quickly), stolen research and IP can be exploited for years.
1. Trade Secrets Theft Is a Billion-Dollar Problem
If your groundbreaking research ends up in the wrong hands, don’t expect an apology—expect to see a competing product hit the market before yours. Take the case of GlaxoSmithKline scientist Yu Xue, who stole proprietary drug formulas and attempted to sell them to China. The case led to multiple arrests and billions in potential damages (DOJ, 2018).
2. Insider Threats Are an Expensive Oversight
Not all threats come from anonymous hackers. Sometimes, it’s your own employees, contractors, or research partners. Insider incidents cost companies an average of $16.2 million per breach in 2023 (Ponemon Institute). Without the right controls in place, your R&D data is only one disgruntled employee away from disaster.
3. Your Supply Chain Is Your Weakest Link
You might have top-notch cybersecurity, but what about your third-party vendors? A single compromised partner can expose your entire operation. Just ask Merck, whose supply chain was infiltrated by the NotPetya malware, causing $1.4 billion in damages and disrupting vaccine production (Insurance Business, 2024).
These risks highlight the urgent need for strong security awareness training and a positive security culture. It’s not enough to rely on technology alone—your employees, partners, and suppliers must understand the threats and know how to respond. A well-trained workforce can act as a frontline defense against cyberattacks, reducing the risk of human error and insider threats.
The Fix: Smarter Security Training (Without the Snoozefest)
I get it. You didn’t start a biotech company to spend hours in cybersecurity workshops. But here’s the thing: your team is your first line of defence. And most breaches? They happen because of human error.
How to Make Security Training Work:
- Keep it short & frequent – No one remembers an annual compliance webinar. Bite-sized, regular training (think 5-minute refreshers) sticks better.
- Make it real – Forget vague “cyber hygiene” talks. Use real case studies (like the GlaxoSmithKline case) to make lessons hit home, and link it to your information protection program.
- Make it personal – People care when they are at risk. Show how security mistakes can impact their pay, data, and job stability.

The Bottom Line: Cybersecurity Is an Investment, Not a Cost
If you’re serious about protecting your research, IP, and funding, security training needs to be as essential as your next investor pitch.
What to Do Next:
- ✅ Review your security training program—does it actually work?
- ✅ Audit your supply chain partners for security gaps.
- ✅ Implement controls to detect insider threats before they happen.
- ✅ Stop treating cybersecurity as an IT issue—it’s a business risk.
The choice is yours: invest in security now or pay the price later. Which will it be?
Further Reading
- Blackkite (2025). Healthcare under ransomware attack 2025 report
- Curwell, P. (2021). How is confidential information compromised?
- Curwell, P. (2022). Business Espionage: the sale of IP on the dark web.
- Department of Justice (2018). Former GlaxoSmithKline scientist pleads guilty to stealing trade secrets
- Insurance Business (2024). Merck settles $1.4bn cyberattack case against insurers.
DISCLAIMER: All information presented on paulcurwell.com is intended for general information purposes only. The content of paulcurwell.com should not be considered legal or any other form of advice or opinion on any specific facts or circumstances. Readers should consult their own advisers experts or lawyers on any specific questions they may have. Any reliance placed upon paulcurwell.com is strictly at the reader’s own risk. The views expressed by the authors are entirely their own and do not represent the views of, nor are they endorsed by, their respective employers. Refer here for full disclaimer.